Show
Sort by
-
- Journal Article
- A1
- open access
Randomized phase I : safety, immunogenicity and mucosal antiviral activity in young healthy women vaccinated with HIV-1 Gp41 P1 peptide on virosomes
-
The influence of laboratory-induced MELD score differences on liver allocation: more reality than myth
-
IL28B polymorphism and the control of hepatitis C virus infection: ready for clinical use ?
-
Efficacy of interferon-based antiviral therapy in patients with chronic hepatitis C infected with genotype 5: a Meta-analysis of two large prospective clinical trials
-
- Journal Article
- A1
- open access
Response-guided telaprevir combination treatment for hepatitis C virus infection
-
Outcome of patients with hepatocellular carcinoma listed for liver transplantation before and after the Meld-based allocation system within Eurotransplant: a Belgian multicentre retrospective study
-
A randomized, open-label, multicenter study evaluating the efficacy of peginterferon alfa-2a versus interferon alfa-2a, in combination with ribavirin, in naïve and relapsed chronic hepatitis C patients
-
- Journal Article
- A1
- open access
Effectiveness and tolerability of pegylated interferon alfa-2b in combination with ribavirin for treatment of chronic hepatitis C: the PegIntrust Study
-
Clinical trial: a randomized trial of pegylated-interferon-alpha-2a plus ribavirin with or without amantadine in treatment-naive or relapsing chronic hepatitis C patients
-
Outcome of patients with hepatocellular carcinoma listed for liver transplantation within the eurotransplant allocation system
-
Weekly Pegylated interferon alpha-2b vs daily interferon a-2b versus standard regimen of interferon a-2b in the treatment of patients with chronic hepatitis C virus infection
-
Management and treatment of chronic hepatitis B virus: Belgian Association for the Study of the Liver (BASL) 2007 guidelines
-
Influence of different laboratory methods on MELD calculation in the Belgian liver transplant centres
-
Early immunosuppression withdrawal after living donor liver transplantation and donor stem cell infusion
-
The management of patients with mild hepatitis C
-
Report on the Belgian consensus meeting on Colorectal cancer screening
-
Practical use of hepatitis C and B molecular tools: Belgian guidelines
-
Patients with hepatocellular carcinoma (HCC) listed for liver transplantation (LTX) outside the MELD system: outcome of a multicenter Eurotransplant series
-
Daily induction combination treatment with alpha 2b interferon and ribavirin or standard combination treatment in naive chronic hepatitis C patients. A multicentre randomized controlled trial
-
Hepatitis C virus: the burden of the disease.
-
Hepatitis C virus genotypes : epidemiological and clinical associations
-
Efficacy of interferon dose and prediction of response in chronic hepatitis C: Benelux study in 336 patients.
-
Diuretic requirements after therapeutic paracentesis in non-azotemic patients with cirrhosis. A randomized double-blind trial of spironolactone versus placebo
-
Early administration of somatostatin and efficacy of sclerotherapy in acute oesophageal variceal bleeds: the European acute bleeding oesophageal variceal episodes (ABOVE) randomised trial.